X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
ADCOCK INGRAM
Jun-14
UNICHEM LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs320367-   
Low Rs221265-   
Sales per share (Unadj.) Rs167.2109.1-  
Earnings per share (Unadj.) Rs12.0-27.5-  
Cash flow per share (Unadj.) Rs16.9-22.8-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs117.085.7-  
Shares outstanding (eoy) m90.88168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.62.9 55.9%   
Avg P/E ratio x22.6-11.5 -197.0%  
P/CF ratio (eoy) x16.0-13.9 -115.3%  
Price / Book Value ratio x2.33.7 62.7%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m24,57853,291 46.1%   
No. of employees `0005.24.3 120.9%   
Total wages/salary Rs m2,4873,345 74.4%   
Avg. sales/employee Rs Th2,928.34,290.3 68.3%   
Avg. wages/employee Rs Th479.4779.1 61.5%   
Avg. net profit/employee Rs Th209.4-1,081.1 -19.4%   
INCOME DATA
Net Sales Rs m15,19518,418 82.5%  
Other income Rs m110129 85.4%   
Total revenues Rs m15,30518,547 82.5%   
Gross profit Rs m1,788-3,192 -56.0%  
Depreciation Rs m452795 56.8%   
Interest Rs m34499 6.8%   
Profit before tax Rs m1,413-4,357 -32.4%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m326272 119.7%   
Profit after tax Rs m1,087-4,641 -23.4%  
Gross profit margin %11.8-17.3 -67.9%  
Effective tax rate %23.1-6.2 -369.1%   
Net profit margin %7.2-25.2 -28.4%  
BALANCE SHEET DATA
Current assets Rs m6,42613,490 47.6%   
Current liabilities Rs m3,9177,590 51.6%   
Net working cap to sales %16.532.0 51.5%  
Current ratio x1.61.8 92.3%  
Inventory Days Days68111 61.0%  
Debtors Days Days77124 62.1%  
Net fixed assets Rs m7,4107,863 94.2%   
Share capital Rs m18286 212.6%   
"Free" reserves Rs m10,4540-   
Net worth Rs m10,63614,456 73.6%   
Long term debt Rs m45,080 0.1%   
Total assets Rs m15,25827,309 55.9%  
Interest coverage x42.9-7.7 -555.0%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x1.00.7 147.7%   
Return on assets %7.3-15.2 -48.4%  
Return on equity %10.2-32.1 -31.8%  
Return on capital %13.6-19.8 -68.6%  
Exports to sales %24.10-   
Imports to sales %4.90-   
Net fx Rs m5,2980-   
CASH FLOW
From Operations Rs m6831,572 43.5%  
From Investments Rs m-1,316-483 272.5%  
From Financial Activity Rs m5924,611 12.8%  
Net Cashflow Rs m-405,700 -0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.06 Rs / ZAR

Compare UNICHEM LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: TORRENT PHARMA  PFIZER  JUBILANT LIFE SCIENCES  SHASUN PHARMA  AJANTA PHARMA  



Today's Market

Sensex Trades Rangebound; Metal, Pharma Stocks Top Losers(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading below the dotted line.

Related Views On News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 18, 2018 03:15 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - NATCO PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS